BioPlus Specialty Pharmacy announced Thursday that URAC, the largest accrediting body for health care, has once again given BioPlus its seal of approval by accrediting it through an on-site process.
Specialty Pharmacy News
BioPlus Specialty Pharmacy on Tuesday earned accreditation from two important industry accrediting bodies: Verified Internet Pharmacy Practice Sites and Accreditation Commission for Health Care.
HIV patients using a mobile app are 2.9 times more likely to be adherent.
The Food and Drug Administration last week approved Natpara (parathyroid horomone), which is indicated to control low blood calcium levels in patients who have hypoparathyroidism.
With specialty and biotech drugs claiming an ever-greater share of the pharmaceutical market and spawning a backlash from payers and patients over their high price tags, pharmacy operators are smack in the middle of a growing tug of war between the drug industry, the public and private health plans struggling to keep up with the new drug-cost paradigm.
Drug Channels Institute on Tuesday offered a sneak peek to its 2014-15 Economic Report on Retail, Mail and Specialty Pharmacies with a look at the largest pharmacies, ranked by total U.S. prescription dispensing revenues for calendar year 2014.
Walgreens on Tuesday announced that it has signed a definitive agreement with Madison Dearborn Partners, a leading private equity firm based in Chicago, under which MDP will acquire a majority interest in Walgreens Infusion Services.
Diplomat Pharmacy on Tuesday announced the addition of Susan Faust to their senior leadership team as VP specialty infusion and market development.
AbbVie announced that the Food and Drug Administration has approved its Duopa (carbidopa and levodopa) enteral suspension, which is used to treat motor fluctuations for people with advanced Parkinson's disease.
Walgreens on Thursday announced that effective immediately, Walgreens Infusion Services will serve as a limited network home infusion provider for Blincyto (blinatumomab).